FFR vs. Angiography: Improving PCI Outcomes & Assessing Stenosis Accuracy
The assessment of coronary artery disease is evolving, moving beyond visual interpretation of angiograms to incorporate physiological measurements of blood flow. This shift is particularly relevant for patients undergoing valve surgery who may also have significant coronary artery disease. Recent evidence suggests that using fractional flow reserve (FFR) – a technique to measure the functional significance of a narrowing in a coronary artery – provides a more accurate assessment than angiography alone, and can lead to improved outcomes when guiding treatment decisions like percutaneous coronary intervention (PCI).
Understanding the Limitations of Angiography
For decades, coronary angiography has been the standard for visualizing the coronary arteries. However, angiography only provides a static image of the vessel’s anatomy. It can identify the presence of a narrowing, or stenosis, but not necessarily its functional significance. A visually significant narrowing might not actually be restricting blood flow enough to cause symptoms or harm the heart muscle. Conversely, a seemingly mild narrowing can sometimes have a substantial impact on blood flow. What we have is where FFR comes in.
FFR directly measures the pressure difference across a coronary artery stenosis during maximal blood flow. Essentially, it determines how much blood flow is being restricted by the narrowing. A lower FFR value indicates a more significant restriction of blood flow. This information helps clinicians determine whether a narrowing warrants intervention, such as PCI – a procedure to open blocked arteries using a balloon and often a stent.
FFR and PCI Outcomes: What the Evidence Shows
Studies have demonstrated the benefits of FFR-guided PCI. A study published in the New England Journal of Medicine in 2009 showed that routine measurement of FFR in patients with multivessel coronary artery disease undergoing PCI with drug-eluting stents significantly reduced the rate of major adverse cardiac events. This suggests that identifying and treating only those stenoses that are truly causing ischemia – a lack of blood flow to the heart muscle – can improve patient outcomes.
Further research, including a publication in Circulation in 2014, reinforces the concept that clinical benefit from PCI is confined to coronary artery stenoses that actually restrict blood flow. The study highlights that intervening on non-flow-limiting lesions doesn’t provide additional benefit and may even expose patients to unnecessary risks associated with the procedure.
Angiography-Derived FFR: A Less Invasive Approach
Traditionally, obtaining an FFR reading requires inserting a pressure wire into the coronary artery and administering medications to induce maximal blood flow. However, a newer technique called angiography-derived FFR (dFFR) offers a less invasive alternative. DFFR estimates FFR from standard coronary angiography images using computational fluid dynamics. According to information from the National Institutes of Health’s National Center for Biotechnology Information, dFFR shows good correlation with invasive, wire-based FFR. Which means dFFR can potentially provide similar information without the need for a pressure wire or hyperaemic agents.
Implications for Patients Undergoing Valve Surgery
The integration of FFR, or dFFR, into the evaluation of patients undergoing valve surgery is particularly important. These patients often have multiple co-existing conditions, including coronary artery disease. Determining the optimal timing and extent of coronary revascularization – restoring blood flow to the heart – in conjunction with valve surgery can be complex. Physiologically guided PCI, using FFR, can support clinicians make more informed decisions about which lesions to treat, potentially minimizing the risk of complications and improving long-term outcomes.
It’s crucial to understand that FFR is a tool to aid in decision-making, not a definitive answer. The decision to proceed with PCI should always be made on a case-by-case basis, considering the patient’s overall clinical condition, symptoms, and other relevant factors. FFR provides valuable physiological information, but it doesn’t replace the need for careful clinical judgment.
What Comes Next: Refining Guidelines and Expanding Access
The use of FFR and dFFR is continually being evaluated and refined. Ongoing research is focused on identifying which patients are most likely to benefit from physiologically guided PCI, and on optimizing the techniques for measuring FFR and dFFR. Professional societies are also working to update guidelines to incorporate the latest evidence on the role of FFR in the management of coronary artery disease.
efforts are underway to increase access to FFR and dFFR technology, particularly in smaller hospitals and communities where it may not currently be available. Wider adoption of these techniques could lead to more consistent and evidence-based care for patients with coronary artery disease.
Patients with concerns about coronary artery disease or who are scheduled for valve surgery should discuss their individual risk factors and treatment options with a qualified cardiologist. Open communication with your healthcare provider is essential for making informed decisions about your care.